Loading
AI
Arqule Inc Stock: price and insider trades · United States
Arqule Inc: what insiders have been doing
Insider filings for Arqule Inc are scarce in the SEC (Form 4) feed, the latest one published on 20 January 2016. This page will fill in as new trades are disclosed. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2018FY ended December 2018 · cache
Income statement
Net income-US$13.4M
Last declaration on 20 January 2016
Declarations6 total
670 sharesCommon StockSEC:0001019695-16-000059:0
558 sharesCommon StockSEC:0001019695-16-000060:0
2,872 sharesCommon StockSEC:0001019695-16-000056:0
2,847 sharesCommon StockSEC:0001019695-16-000057:0
1,215 sharesCommon StockSEC:0001019695-16-000058:0
595 sharesCommon StockSEC:0001019695-16-000055:0
6 of 6 declarations
About Arqule Inc
Arqule Inc is a NASDAQ-listed company focused on developing treatments for cancer. It specializes in research and the discovery of innovative drugs.
